荷兰肌萎缩侧索硬化患者安乐死频率、终末期实践相关因素及终末期护理质量:基于人群的队列研究
基于荷兰ALS登记处的基于人群的队列研究,纳入2014-2016年死亡的884例ALS患者,分析安乐死频率、终末期实践相关因素及护理质量。结果显示2014-16年安乐死频率为40%(141/356),高于1994-98年的17%和2000-05年的16%;选择安乐死与未选择者中位生存期无显著差异(HR 1.07,95%CI 0.85-1.34;p=0.58)。照护者报告患者对终末期护理总体质量及可及性满意。
要点
- 2014-16年ALS患者安乐死频率为40%(141/356),高于1994-98年(17%)和2000-05年(16%)。
- 选择安乐死与未选择者中位生存期无显著差异(HR 1.07,95%CI 0.85-1.34;p=0.58)。
- 照护者报告选择安乐死者更常报告无改善机会、失去尊严、依赖和疲劳或极度虚弱作为加速死亡原因。
核心结论
- 自2002年以来荷兰ALS患者选择安乐死的比例增加,选择安乐死与疾病或患者特征、抑郁或无望感、终末期护理可及性或质量无关,对总生存无影响。
研究设计与样本
- 基于荷兰ALS登记处的基于人群的队列研究,纳入2014年1月1日至2016年12月31日死亡的884例符合修订El-Escorial标准的ALS患者。
- 从2012年至2020年安乐死审查委员会(ERC)报告中计算安乐死频率,并与1994-2005年临床调查研究比较。
主要发现
- 2012年1月1日至2020年12月31日,ERC收到4130例ALS死亡报告,其中1014例为安乐死或医生协助自杀(年均频率25%,SD 3)。
- 2014-16年安乐死频率为40%(141/356),高于1994-98年的17%(35/203)和2000-05年的16%(33/209)。
- 选择安乐死与未选择者中位生存期无显著差异:15.9个月(95%CI 12.6-17.6)vs 16.1个月(13.4-19.1),HR 1.07(95%CI 0.85-1.34;p=0.58)。
- 照护者报告选择安乐死者加速死亡原因:无改善机会56%(53/94)vs 39%(28/72),失去尊严50%(47/94)vs 21%(15/72),依赖36%(34/94)vs 7%(5/72),疲劳或极度虚弱44%(41/94)vs 20%(14/72)。
- 照护者报告患者对终末期护理总体质量满意:选择安乐死93%(83/89)vs 未选择86%(73/85);可及性满意:97%(85/88)vs 91%(81/90)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amyotrophic lateral sclerosis is a progressive and lethal neurodegenerative disease that is at the forefront of debates on regulation of assisted dying. Since 2002, when euthanasia was legally regulated in the Netherlands, the frequency of this end-of-life practice has increased substantially from 1·7% of all deaths in 1990 and 2005 to 4·5% in 2015. We aimed to investigate whether the frequency of euthanasia in patients with amyotrophic lateral sclerosis had similarly increased since 2002, and to assess the factors associated with end-of-life practices and the quality of end-of-life care in patients with this disease. METHODS: Using data from the Netherlands ALS registry, we did a population-based cohort study of clinicians and informal caregivers of patients with amyotrophic lateral sclerosis to assess factors associated with end-of-life decision making and the quality of end-of-life care. We included individuals who were diagnosed with amyotrophic lateral sclerosis according to the revised El-Escorial criteria, and who died between Jan 1, 2014, and Dec 31, 2016. We calculated the frequency of euthanasia in patients with amyotrophic lateral sclerosis from reports made to euthanasia review committees (ERCs) between 2012 and 2020. Results were compared with clinic-based survey studies conducted in 1994-2005. End-of-life practices were end-of-life decisions by a clinician when hastening of death was considered as the potential, probable, or definite effect comprising euthanasia, physician-assisted suicide, ending of life without explicit request, forgoing life-prolonging treatment, and intensified alleviation of symptoms. FINDINGS: Between Jan 1, 2012, and Dec 31, 2020, 4130 reports of death from amyotrophic lateral sclerosis were made to ERCs, of which 1014 were from euthanasia or physician-assisted suicide (mean frequency 25% [SD 3] per year). Sex and gender data were unavailable from the ERC registry. Of 884 patients with amyotrophic lateral sclerosis who died between Jan 1, 2014, and Dec 31, 2016, their treating clinician was identified for 731 and a caregiver was identified for 741, of whom 356 (49%) and 450 (61%), respectively, agreed to participate in the population-based survey study. According to clinicians, end-of-life practices were chosen by 280 (79%) of 356 patients with amyotrophic lateral sclerosis who died. The frequency of euthanasia in patients with amyotrophic lateral sclerosis in 2014-16 (141 [40%] of 356 deaths in patients with amyotrophic lateral sclerosis) was higher than in 1994-98 (35 [17%] of 203) and 2000-05 (33 [16%] of 209). Median survival of patients with amyotrophic lateral sclerosis from diagnosis was 15·9 months (95% CI 12·6-17·6) for those who chose euthanasia and 16·1 months (13·4-19·1) for those who did not choose euthanasia (hazard ratio 1·07, 95% CI 0·85-1·34; p=0·58). According to caregivers, compared with other end-of-life practices, patients with amyotrophic lateral sclerosis choosing euthanasia commonly reported reasons to hasten death as no chance of improvement (53 [56%] of 94 patients who chose euthanasia vs 28 [39%] of 72 patients who chose other end-of-life practices), loss of dignity (47 [50%] vs 15 [21%]), dependency (34 [36%] vs five [7%]), and fatigue or extreme weakness (41 [44%] vs 14 [20%]). According to caregivers, people with amyotrophic lateral sclerosis-whether they chose euthanasia or did not-were satisfied with the general quality (83 [93%] of 89 patients who chose euthanasia vs 73 [86%] of 85 patients who did not) and availability (85 [97%] of 88 vs 81 [91%] of 90) of end-of-life care. INTERPRETATION: The proportion of patients with amyotrophic lateral sclerosis who chose euthanasia in the Netherlands has increased since 2002. The choice of euthanasia was not associated with disease or patient characteristics, depression or hopelessness, or the availability or quality of end-of-life care. The choice of euthanasia had no effect on overall survival. Future studies could focus on the effect of discussing end-of-life options on quality of life as part of multidisciplinary care throughout the course of the disease, to reduce feelings of loss of autonomy and dignity in patients living with amyotrophic lateral sclerosis. FUNDING: Netherlands ALS Foundation.
引用
- van Eenennaam RM, Kruithof W, Beelen A, et al. Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort study. Lancet Neurol. 2023. PMID: 37353279. doi:10.1016/S1474-4422(23)00155-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。